Opicapone-D6,15N
CAS: 923287-50-7
Ref. 3D-YLB28750
| 1mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued |
Product Information
- 1,2-Benzenediol, 5-[3-(2,5-dichloro-4,6-dimethyl-1-oxido-3-pyridinyl)-1,2,4-oxadiazol-5-yl]-3-nitro-
- 2,5-Dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine 1-oxide
- 5-[3-(2,5-Dichloro-4,6-dimethyl-1-oxido-3-pyridinyl)-1,2,4-oxadiazol-5-yl]-3-nitro-1,2-benzenediol
- 5-[3-(2,5-Dichloro-4,6-dimethyl-1-oxy-pyridin-3-yl)-[1,2,4]oxadiazol-5-yl]-3-nitrobenzene-1,2-diol
- Bia 9-1067
- Ongentys
- Opicapone
Opicapone-D6.15N is a unique compound with multiple characteristics. It acts as an antimuscarinic agent and has phosphorescent properties. Opicapone-D6.15N is also known to interact with n-acetylmannosamine, deflazacort, dopamine inhibitors, adjuvant compositions, gambogic acid, diacetone, steroids, alkaloids, catechol-o-methyltransferase, cellulose, and various research chemicals.
Opicapone-D6.15N is a highly versatile medicament that can be used in different applications due to its wide range of characteristics. Its antimuscarinic properties make it useful for treating conditions related to excessive muscarinic activity in the body. Additionally, its phosphorescent nature makes it suitable for applications in industries such as lighting or fluorescence-based technologies.
The compound Opicapone-D6.15N has shown potential as an inhibitor of dopamine metabolism and can be used as an adjuvant
